BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26383532)

  • 1. Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
    Ben-Shmuel S; Scheinman EJ; Rashed R; Orr ZS; Gallagher EJ; LeRoith D; Rostoker R
    J Endocrinol; 2015 Dec; 227(3):143-151. PubMed ID: 26383532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
    Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
    Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.
    Zelenko Z; Gallagher EJ; Tobin-Hess A; Belardi V; Rostoker R; Blank J; Dina Y; LeRoith D
    Oncogene; 2017 Mar; 36(10):1394-1403. PubMed ID: 27568979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
    Zhao H; Yakar S; Gavrilova O; Sun H; Zhang Y; Kim H; Setser J; Jou W; LeRoith D
    Diabetes; 2004 Nov; 53(11):2901-9. PubMed ID: 15504971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.
    Zelenko Z; Gallagher EJ; Antoniou IM; Sachdev D; Nayak A; Yee D; LeRoith D
    Endocr Relat Cancer; 2016 Sep; 23(9):747-58. PubMed ID: 27435064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model.
    Rostoker R; Bitton-Worms K; Caspi A; Shen-Orr Z; LeRoith D
    Endocrinology; 2013 May; 154(5):1701-10. PubMed ID: 23515289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.
    Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D
    Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.
    Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
    Endocr Relat Cancer; 2010 Dec; 17(4):941-51. PubMed ID: 20801951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis.
    Khalid S; Hwang D; Babichev Y; Kolli R; Altamentova S; Koren S; Goodwin PJ; Ennis M; Pollak M; Sonenberg N; Fantus IG
    Breast Cancer Res Treat; 2010 Aug; 122(3):647-59. PubMed ID: 19851863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.
    Ferguson RD; Gallagher EJ; Cohen D; Tobin-Hess A; Alikhani N; Novosyadlyy R; Haddad N; Yakar S; LeRoith D
    Endocr Relat Cancer; 2013 Jun; 20(3):391-401. PubMed ID: 23572162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
    Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia induces early and dyssynchronous puberty in lean female mice.
    Saleh FL; Joshi AA; Tal A; Xu P; Hens JR; Wong SL; Flannery CA
    J Endocrinol; 2022 Sep; 254(3):121-135. PubMed ID: 35904489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen deficiency aggravates insulin resistance and induces β-cell loss and diabetes in female New Zealand obese mice.
    Vogel H; Mirhashemi F; Liehl B; Taugner F; Kluth O; Kluge R; Joost HG; Schürmann A
    Horm Metab Res; 2013 Jun; 45(6):430-5. PubMed ID: 23322514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.
    Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
    Diabetes; 2010 Mar; 59(3):686-93. PubMed ID: 19959755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones.
    Nunez NP; Perkins SN; Smith NC; Berrigan D; Berendes DM; Varticovski L; Barrett JC; Hursting SD
    Nutr Cancer; 2008; 60(4):534-41. PubMed ID: 18584488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
    Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness.
    Kim CH; Pennisi P; Zhao H; Yakar S; Kaufman JB; Iganaki K; Shiloach J; Scherer PE; Quon MJ; LeRoith D
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E298-305. PubMed ID: 16507604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models.
    LeRoith D
    Diabetes Metab Res Rev; 2010 Nov; 26(8):599-601. PubMed ID: 20941806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.
    Kim H; Pennisi PA; Gavrilova O; Pack S; Jou W; Setser-Portas J; East-Palmer J; Tang Y; Manganiello VC; Leroith D
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1227-36. PubMed ID: 16682489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.